• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Insterspec agreement with Siemens breaks down

Article

Interspec reported this month that its radiology ultrasound R&Dand marketing agreement with Siemens is off. The Ambler, PA, cardiacultrasound supplier had been working with the large German multimodalityimaging vendor to develop a radiology

Interspec reported this month that its radiology ultrasound R&Dand marketing agreement with Siemens is off. The Ambler, PA, cardiacultrasound supplier had been working with the large German multimodalityimaging vendor to develop a radiology ultrasound scanner (SCAN10/24/90).

Siemens would have had international rights to market thescanner once it was developed. Interspec retains worldwide rightsto the technology developed cooperatively. The smaller firm plansto sell the system itself through a combination of direct salesand distribution agreements, according to Edward Ray, chairmanand CEO.

"Interspec will take advantage of this opportunity andexpand its established international distribution to market itsnew product when it becomes available," Ray said.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.